Cognition Therapeutics (CGTX) Current Leases (2022 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Current Leases of $95000.0 for Q1 2026, down 51.03% year-over-year from $194000.0 in Q1 2025, and down 30.15% quarter-over-quarter from $136000.0 in Q4 2025.
Cognition Therapeutics (CGTX) Current Leases (2022 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Current Leases for 5 consecutive years, with $95000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 51.03% year-over-year to $95000.0; the TTM figure through Mar 2026 stood at $95000.0 (down 51.03% YoY), while the FY2025 annual figure was $136000.0, down 29.53% from the prior year.
- Current Leases fell to $95000.0 in Q1 2026 per CGTX's latest filing, from $136000.0 in the prior quarter.
- Across five years, Current Leases topped out at $198000.0 in Q2 2025 and bottomed at $95000.0 in Q1 2026.
- Historically, Current Leases has averaged $163352.9 across 5 years, with a median of $168000.0 in 2025.
- Annual changes were most pronounced in 2023 — Current Leases soared 49.12% — and 2026, when it slumped 51.03%.
- Cognition Therapeutics' Current Leases stood at $149000.0 in 2022, then rose by 16.78% to $174000.0 in 2023, then rose by 10.92% to $193000.0 in 2024, then retreated by 29.53% to $136000.0 in 2025, then plunged by 30.15% to $95000.0 in 2026.
- Business Quant data shows CGTX's Current Leases at $95000.0 in Q1 2026, $136000.0 in Q4 2025, and $168000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89,000.00 |
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | 136,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 184,000.00 |
| Mar 31, 2024 | 180,000.00 |
| Dec 31, 2023 | 174,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 157,000.00 |
| Dec 31, 2022 | 149,000.00 |
| Sep 30, 2022 | 114,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | 150,000.00 |